trans-(1R,2R)-N-[2-(3-ethyl-5-sulfanylidene-1H-1,2,4-triazol-4-yl)ethyl]-2-(trifluoromethyl)cyclohexane-1-carboxamide

C14H21F3N4OS — CID 95933391

IUPACtrans-(1R,2R)-N-[2-(3-ethyl-5-sulfanylidene-1H-1,2,4-triazol-4-yl)ethyl]-2-(trifluoromethyl)cyclohexane-1-carboxamide
SMILESCCc1n[nH]c(=S)n1CCNC(=O)[C@@H]1CCCC[C@H]1C(F)(F)F
InChIInChI=1S/C14H21F3N4OS/c1-2-11-19-20-13(23)21(11)8-7-18-12(22)9-5-3-4-6-10(9)14(15,16)17/h9-10H,2-8H2,1H3,(H,18,22)(H,20,23)/t9-,10-/m1/s1
InChIKeyJBKQPBQXCPWDAS-NXEZZACHSA-N
MW350.41 g/mol
LogP2.99
Rot. Bonds5

About trans-(1R,2R)-N-[2-(3-ethyl-5-sulfanylidene-1H-1,2,4-triazol-4-yl)ethyl]-2-(trifluoromethyl)cyclohexane-1-carboxamide

trans-(1R,2R)-N-[2-(3-ethyl-5-sulfanylidene-1H-1,2,4-triazol-4-yl)ethyl]-2-(trifluoromethyl)cyclohexane-1-carboxamide (PubChem CID 95933391) has the molecular formula C14H21F3N4OS and a molecular weight of 350.41 g/mol. Its IUPAC name is trans-(1R,2R)-N-[2-(3-ethyl-5-sulfanylidene-1H-1,2,4-triazol-4-yl)ethyl]-2-(trifluoromethyl)cyclohexane-1-carboxamide.

Molecular Properties

Compound Nametrans-(1R,2R)-N-[2-(3-ethyl-5-sulfanylidene-1H-1,2,4-triazol-4-yl)ethyl]-2-(trifluoromethyl)cyclohexane-1-carboxamide
PubChem CID95933391
Molecular FormulaC14H21F3N4OS
Molecular Weight350.41 g/mol
Exact Mass350.14
IUPAC Nametrans-(1R,2R)-N-[2-(3-ethyl-5-sulfanylidene-1H-1,2,4-triazol-4-yl)ethyl]-2-(trifluoromethyl)cyclohexane-1-carboxamide
SMILESCCc1n[nH]c(=S)n1CCNC(=O)[C@@H]1CCCC[C@H]1C(F)(F)F
InChIInChI=1S/C14H21F3N4OS/c1-2-11-19-20-13(23)21(11)8-7-18-12(22)9-5-3-4-6-10(9)14(15,16)17/h9-10H,2-8H2,1H3,(H,18,22)(H,20,23)/t9-,10-/m1/s1
InChIKeyJBKQPBQXCPWDAS-NXEZZACHSA-N
XLogP2.99
TPSA62.71 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms23
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500350.41
LogP ≤ 52.99
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze trans-(1R,2R)-N-[2-(3-ethyl-5-sulfanylidene-1H-1,2,4-triazol-4-yl)ethyl]-2-(trifluoromethyl)cyclohexane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of trans-(1R,2R)-N-[2-(3-ethyl-5-sulfanylidene-1H-1,2,4-triazol-4-yl)ethyl]-2-(trifluoromethyl)cyclohexane-1-carboxamide?
The IUPAC name of trans-(1R,2R)-N-[2-(3-ethyl-5-sulfanylidene-1H-1,2,4-triazol-4-yl)ethyl]-2-(trifluoromethyl)cyclohexane-1-carboxamide (CID 95933391) is trans-(1R,2R)-N-[2-(3-ethyl-5-sulfanylidene-1H-1,2,4-triazol-4-yl)ethyl]-2-(trifluoromethyl)cyclohexane-1-carboxamide.
What is the SMILES notation for trans-(1R,2R)-N-[2-(3-ethyl-5-sulfanylidene-1H-1,2,4-triazol-4-yl)ethyl]-2-(trifluoromethyl)cyclohexane-1-carboxamide?
The canonical SMILES for trans-(1R,2R)-N-[2-(3-ethyl-5-sulfanylidene-1H-1,2,4-triazol-4-yl)ethyl]-2-(trifluoromethyl)cyclohexane-1-carboxamide is CCc1n[nH]c(=S)n1CCNC(=O)[C@@H]1CCCC[C@H]1C(F)(F)F.
What is the InChIKey of trans-(1R,2R)-N-[2-(3-ethyl-5-sulfanylidene-1H-1,2,4-triazol-4-yl)ethyl]-2-(trifluoromethyl)cyclohexane-1-carboxamide?
The InChIKey is JBKQPBQXCPWDAS-NXEZZACHSA-N. The full InChI is InChI=1S/C14H21F3N4OS/c1-2-11-19-20-13(23)21(11)8-7-18-12(22)9-5-3-4-6-10(9)14(15,16)17/h9-10H,2-8H2,1H3,(H,18,22)(H,20,23)/t9-,10-/m1/s1.
What are the key properties of trans-(1R,2R)-N-[2-(3-ethyl-5-sulfanylidene-1H-1,2,4-triazol-4-yl)ethyl]-2-(trifluoromethyl)cyclohexane-1-carboxamide?
trans-(1R,2R)-N-[2-(3-ethyl-5-sulfanylidene-1H-1,2,4-triazol-4-yl)ethyl]-2-(trifluoromethyl)cyclohexane-1-carboxamide has a molecular weight of 350.41 g/mol, XLogP of 2.99, 5 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for trans-(1R,2R)-N-[2-(3-ethyl-5-sulfanylidene-1H-1,2,4-triazol-4-yl)ethyl]-2-(trifluoromethyl)cyclohexane-1-carboxamide is sourced from PubChem (CID 95933391), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).